Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate)

Provided By Globe Newswire

Last update: May 18, 2022

JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions